Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.

Bistrovic, Petra; Manola, Sime; Lucijanic, Marko

Bistrovic, Petra; Manola, Sime; Lucijanic, Marko.

Bistrovic P; Cardiology Department, University Hospital Dubrava, Zagreb, Croatia.
Manola S; Cardiology Department, University Hospital Dubrava, Zagreb, Croatia.
Lucijanic M; University of Zagreb, School of Medicine, Zagreb, Croatia.

Postgrad Med J ; 98(1161): 501-502, 2022 07.

Article in English | MEDLINE | ID: covidwho-1562109

Subject(s)

COVID-19 Drug Treatment; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; Bradycardia/chemically induced; Bradycardia/drug therapy; Humans; Retrospective Studies

Keywords

COVID-19; cardiology; infectious diseases

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Postgrad Med J Year: 2022 Document Type: Article Affiliation country: Postgradmedj-2021-141079

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google